Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hormone replacement therapy and risk of breast cancer.
Grant EC. Grant EC. JAMA. 2002 May 8;287(18):2360; author reply 2361. JAMA. 2002. PMID: 11988049 No abstract available.
Estrogen plus progestin and colorectal cancer in postmenopausal women.
Grant EC. Grant EC. N Engl J Med. 2004 Jun 3;350(23):2417-9; author reply 2417-9. doi: 10.1056/NEJM200406033502319. N Engl J Med. 2004. PMID: 15175448 No abstract available.
Oral contraceptives and the risk of breast cancer.
Grant EC. Grant EC. N Engl J Med. 2002 Oct 31;347(18):1448-9; author reply 1448-9. N Engl J Med. 2002. PMID: 12418035 No abstract available.
Estrogen-receptor polymorphism and hormone-replacement therapy.
Grant EC. Grant EC. N Engl J Med. 2002 Sep 5;347(10):762-3; author reply 762-3. N Engl J Med. 2002. PMID: 12214623 No abstract available.
Reduction in mortality from breast cancer: fall in use of hormones could have reduced breast cancer mortality.
Grant EC. Grant EC. BMJ. 2005 Apr 30;330(7498):1024; author reply 1025. doi: 10.1136/bmj.330.7498.1024-a. BMJ. 2005. PMID: 15860833 Free PMC article. No abstract available.
Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
Grant EC. Grant EC. J Natl Cancer Inst. 2011 Jul 6;103(13):1069; reply 1069-70. doi: 10.1093/jnci/djr191. Epub 2011 Jun 23. J Natl Cancer Inst. 2011. PMID: 21700925 No abstract available.
Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy.
Grant ECG. Grant ECG. Am J Obstet Gynecol. 2017 Aug;217(2):232-233. doi: 10.1016/j.ajog.2017.05.005. Epub 2017 May 11. Am J Obstet Gynecol. 2017. PMID: 28502754 No abstract available.
Oral contraceptives and risk of breast cancer.
Grant EC. Grant EC. Lancet. 1994 Nov 12;344(8933):1364. Lancet. 1994. PMID: 7968046 No abstract available.
Breast cancer and hormone exposure.
Grant EC, Antony HM, Myhill S, Price EH, Steel CM. Grant EC, et al. Lancet. 1996 Sep 7;348(9028):682; author reply 683. doi: 10.1016/S0140-6736(05)65103-3. Lancet. 1996. PMID: 8782768 No abstract available.
Risks of hormone replacement therapy.
Grant EC, Price EH, Steel CM. Grant EC, et al. Lancet. 1999 Oct 9;354(9186):1302-3. doi: 10.1016/s0140-6736(05)76078-5. Lancet. 1999. PMID: 10520664 No abstract available.
76 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback